Page last updated: 2024-11-04

suramin and Carcinoma, Adenosquamous

suramin has been researched along with Carcinoma, Adenosquamous in 2 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lokshin, A2
Levitt, ML2
Peng, X1
Campbell, PG1
Barsouk, A1

Other Studies

2 other studies available for suramin and Carcinoma, Adenosquamous

ArticleYear
Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.
    Journal of cellular biochemistry. Supplement, 1996, Volume: 24

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Calcimycin; Carcinoma, Adenosquamous; Carcinoma, S

1996
Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Cell Division; Dime

1999